Marinus Pharma Stock (NASDAQ: MRNS) stock price, news, charts, stock research, profile.
Open | $1.47 |
Close | $1.48 |
Volume / Avg. | 350.85K / 1.25M |
Day Range | 1.46 - 1.52 |
52 Wk Range | 1.10 - 11.26 |
Market Cap | $81.85M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 56 |
Short Interest | 8.56% |
Days to Cover | 2.41 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Marinus Pharma (NASDAQ:MRNS) through any online brokerage.
Other companies in Marinus Pharma’s space includes: Universe Pharmaceuticals (NASDAQ:UPC), SCYNEXIS (NASDAQ:SCYX), Ocuphire Pharma (NASDAQ:OCUP), Rani Therapeutics Hldgs (NASDAQ:RANI) and Nutriband (NASDAQ:NTRB).
There is no analysis for Marinus Pharma.
Marinus Pharma has a consensus price target of $13.90.
The stock price for Marinus Pharma (NASDAQ: MRNS) is $1.49 last updated July 23, 2024 at 7:18 PM EDT.
There are no upcoming dividends for Marinus Pharma.
Marinus Pharma’s Q2 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for Marinus Pharma.
Marinus Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.